Edwards SAPIEN 3 Transcatheter Heart Valve System with Edwards Commander Delivery System
Edwards Lifesciences, LLC · Decision date Aug 31, 2020
What did the FDA approve?
The FDA record P200015, decided August 31, 2020, covers the Edwards SAPIEN 3 Transcatheter Heart Valve System with the Edwards Commander Delivery System, a percutaneously delivered pulmonary valve prosthesis (product code NPV) from Edwards Lifesciences, LLC. The stated indication is management of pediatric and adult patients with a clinical indication for intervention on a dysfunctional right ventricular outflow tract conduit or surgical bioprosthetic valve in the pulmonic position, with greater than or equal to moderate regurgitation and/or a mean RVOT gradient of greater than or equal to 35 mmHg.
The supplied fields carry no supplement type or supplement reason and do not identify a prior PMA or a specific changed item. The identifier alone does not establish a supplement relationship, so the record is described only as an approval of the named system. The statement is the applicant's reported intended use; it does not by itself demonstrate safety or clinical effectiveness.
FDA approval order statement
Approval for the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) System with Commander Delivery System is indicated for use in the management of pediatric and adult patients who have a clinical indication for intervention on a dysfunctional right ventricular outflow tract (RVOT) conduit or surgical bioprosthetic valve in the pulmonic position with greater than or equal to moderate regurgitation and/or a mean RVOT gradient of greater than or equal to 35 mmHg.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 31, 2020
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P200015
- Regulatory pathway
- Premarket approval application
- Applicant
- Edwards Lifesciences, LLC
- Product code
- NPV
- Decision code
- APPR
- Decision date
- Aug 31, 2020
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Pulmonary valve prosthesis percutaneously delivered.
- Applicant
- Edwards Lifesciences, LLC
- Product code
- NPV
- FDA device class
- f
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P200015 received
Application receipt date recorded by FDA.
P200015 · FDA decision
APPR
P200015/S083 · Related supplement
Edwards Crimper (9600LDS20, 9600LDS23, 9600LDS26, 9600LDS29)
P200015/S077 · Related supplement
SAPIEN 3 Transcatheter Pulmonary Valve System with Alterra C Adaptive Prestent
P200015/S084 · Related supplement
Edwards SAPIEN 3 Transcatheter Heart Valve (9600TFX)
Timeline entries are records held by MedtechLedger for P200015. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200015
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Edwards Lifesciences, LLC | PMA supplement | Sep 23, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 27, 2026 | FDA | |
| Edwards Lifesciences, LLC | PMA supplement | Oct 28, 2026 | FDA |
Explore the linked device profile
Other records with product code NPV
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Harmony TPV SystemP200046/S052 | Medtronic, Inc. | PMA supplement | Sep 30, 2026 | FDA |
Harmony TPV SystemP200046 | Medtronic, Inc. | PMA approval | Mar 26, 2021 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Edwards Lifesciences, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- One Edwards Way, Irvine, CA, 92614
Sources and methodology
- Original FDA record: P200015
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


